Skip to content

Change in Disease Activity with Exercise Tolerance in Persons with Ankylosing Spondylitis on Adalimumab Therapy

Comparing Change in Disease Activity with Exercise Tolerance in Persons with Ankylosing Spondylitis on Adalimumab Therapy- An Observational Pilot Study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/016947
Enrollment
22
Registered
2019-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M450- Ankylosing spondylitis of multiplesites in spine

Interventions

Intervention1: Six Minute walk test.: The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed cases of AS on Adalimumab therapy from any Department at AIIMS, New Delhi 2. Those who are willing to participate in the study

Exclusion criteria

Exclusion criteria: 1.Any neurological disorders such as stroke, Parkinsonâ??s disease, Traumatic brain injury, Seizure disorder 2.Cognitive impairments 3.Vestibular problems like vertigo, dizziness or ringing of ear 4.Any visual impairment that canâ??t be corrected by glasses 5.Previous surgery at spine and on lower extremities 6.Pregnancy 7.Active substance or alcohol abuse 8.Other disabling medical (Diabetes Mellitus, Uncontrolled hypertension) or psychiatric Co - Morbidities 9.Patients on Biologicals other than Adalimumab. 10. Patients who are unwilling to participate

Design outcomes

Primary

MeasureTime frame
1.To assess change in a)Disease activity using BASDAI b)Exercise tolerance using the 6 minute walk test in patients with AS while on Adalimumab therapy 2.To correlate change in disease activity with exercise tolerance Timepoint: Baseline, 2 weeks and 4 weeks

Secondary

MeasureTime frame
To correlate change in disease activity with exercise toleranceTimepoint: Baseline, 2 weeks and 4 weeks

Countries

India

Contacts

Public ContactDr Abhimanyu Vasudeva

Department of PMR, AIIMS, New Delhi

slyaiims@yahoo.co.in9560678577

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026